Long-lasting remission induced by rituximab in two cases of refractory autoimmune haemolytic anaemia due to cold agglutinins

Documenti analoghi

• Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab?
  di: Palombi, Massimiliano, et al.
  Pubblicazione: (2016)
• Primary acquired chronic pure red cell aplasia refractory to standard treatments: remission with rituximab
  di: Tendas, Andrea, et al.
  Pubblicazione: (2016)
• Cold autoimmune hemolytic anemia resolved by rituximab
  di: Palombi, Massimiliano, et al.
  Pubblicazione: (2010)
• Managing myelodysplastic syndromes in very old patients: a teaching case report
  di: Niscola, Pasquale, et al.
  Pubblicazione: (2013)
• Long-term survival of a patient with bone marrow gelatinous degeneration of idiopathic origin
  di: Niscola, Pasquale, et al.
  Pubblicazione: (2012)